WuXi STA, a subsidiary of WuXi AppTec, has stared operation of a new parenteral formulation manufacturing line at the drug product site in Wuxi city, China.   It is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units. This expansion demonstrates the company’s continuous commitment to enhance its injectable drug product platform.   This new line features a fully automatic vial loading/unloading system ...